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ABSTRACT 
 
Human cytomegalovirus (hCMV) has been described as an important etiological agent of intrauterine infection in women 
of childbearing age that causes congenital malformation. In the present study we examined 844 serum samples from 
women of child-bearing age for the presence of IgM and IgG antibodies against hCMV by Elisa technique. 764 out of 
844 (93%) of the cases were seropositive for hCMV-IgG and 45 (5.4%) cases were seropositive for hCMV-IgM. An 
increase in the rate of IgG seroprevalance was associated with an increase in age and parity. The IgG seroprevalance 
rate was inversely proportional to increasing abortions. Intrestingly seasonal variation affected IgG seroprevalance. 
There was an increasing trend in IgM positivity rate with age in women less than 29 years. hCMV seroprevalence rate 
was higher in women from rural as compared to those of urban areas. Finally hCMV primary infections occured in 2.4 % 
of all pregnancis and it is estimated that up to 0.3% of all congenital disorders, through out Fars province, were due to 
hCMV. We suggest a role of child to mother hCMV transmission and sexual maturity as the most probable 
epidemiological factors of hCMV seroprevalence among women of child bearing age. 
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INTRODUCTION 
 
Human cytomegalovirus (hCMV) seroprevalence varies 
in different populations and age groups. Congenital 
malformation is the most resulting clinical symptom of 
hCMV intrauterine infection (Stagno et al., 1986; Demler, 
1991; Brooks et al., 2001; Gaytant et al., 2002). Up to 
15% of intrauterine hCMV infections led to congenital 
symptomatic diseases. Asymptomatic congenital hCMV 
infection will develop in 10-15% of infants (Boppana et al., 
1992; Fowler et al., 1997; Dahle et al., 2000). Intra uterus 
transmission of hCMV can occur during primary maternal 
infection, reactivation, or reinfection of seropositive 
mothers. Primary hCMV
 infections are transmitted more 
frequently to the fetus and
 are
   more likely to cause fetal 
damage than recurrent infections (Stagno et al., 1986; 
Boppana et al., 1992; Fowler et al., 1992; Fowler et al., 
1997; Dahle et al., 2000). If strategies for the prevention 
of hCMV disease are to be successfully developed, 
knowledge regarding the epidemiology of the virus is 
prerequisite. However, a number of hCMV features, 
including endemic world wide infection, complex natural 
history, unusual relationship with infected host, ubiquity 
of infection, and lack of clinical symptoms in most cases, 
complicate the understanding of the epidemiology of 
hCMV infection (Forbes, 1989). In this study we 
examined the association of hCMV seroprevalence with 
some epidemiological risk factors in women of 
childbearing age.    
 
 
MATERIALS AND METHODS 
 
During 2001 to 2005 serum samples from 844 women at 
child bearing age (15 to 44 years old) that belonged to 
different geographical regions of Fars province were 
collected and stored at -20 °C until usage every week. 
The samples were screened for Specific IgM and IgG 
against hCMV antibodies according to manufacturer's 
instruction (Trinity Biotech co). The results were then 
interpreted on the basis of antibody titers as seropositive, 
seronegative and equivocal. Patients with positive IgM 
were checked for seroconversion two week later. Among 
patients that were positive for IgM only cases with 
seroconversion or high IgM titer (Prince et al., 2002) were 
considered as primary hCMV infections as previously 
described (Revello and Gerna, 2002). Patients that were 
simultaneously negative for IgM and IgG antibodies 
considered as susceptible to hCMV primary infection; 
whereas those with positive IgG and negative IgM were 
considered as resistant. Beside serological screening 
tests for hCMV; total and differential counting of white 
blood cells (WBCs) was carried out for each case for 
further analysis. 
 
RESULTS 
 
hCMV IgM seroprevalence    
45 out of 844 (5.4%) cases were seropositive for hCMV-
IgM antibodies. Among positive IgM cases 35.6 % (Pal et 
al., 1972) were from Shiraz urban area; whereas 4.4 % 
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(Demler, 1991) were from rural areas, the rest of them 
belonged to other cities of Fars province. 
Statistical analysis showed that there was no 
significant linear correlation (Pearson Correlation) 
between increasing in IgM seroprevalence and 
increasing in age (p=  0.65), increasing congenital 
disorders (p= 0.25) and increasing abortions (p= 0.65). 
On the other hand increasing in IgM seroprevalence 
associated with increasing gestations and parity numbers 
(p<.05). 
Maximum IgM seroprevalence rate occurred in 
women between 25-29 years old (Figure 1c). Further 
statistical analysis revealed that there was no significant 
linear correlation (Pearson Correlation test) between an 
increase in age and an increase in hMPV infection rate; 
although the rate of hCMV infection showed a strong 
correlation with age group 15-29 years (p= 0.04), versus 
age group29-39 years (p= 0.27).More over a soar in IgM 
seroprevalence associated with age until 29 years.   
IgM seroprevalence rate was more in women from 
rural as compared to those of urban areas. In addition 
IgM seroprevalence rate was higher in married women in 
comparison with those of single ones, yet these findings 
were not statistically significant.  
Data indicated that there was significant difference 
between hCMV-IgM positive rate in pregnant (in 9th 
Week or more of their gestations) versus non-pregnant 
women in favor of pregnant women (p= 0.03).  
2.3 % (Revello and Gerna, 2002) of all cases had 
primary or acute hCMV infections. Among pregnant 
women 2.4% had primary infections. Also it was revealed 
that maximum primary infections rate belonged to women 
between 20-29 years.  Primary infections rate was higher 
in women from urban as compared to those of rural 
areas; whereas the reverse was true for recurrent or 
reinfections rate (Table1). Demographic data and 
hematological indexes association with the presence of 
hCMV primary infection are reported in Table 1. 
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hCMV IgG seroprevalence   
764 (92.9%) out of 844 cases were seropositive for 
hCMV-IgG antibodies. Statistical analysis revealed that 
congenital disorders (p= 0.67) wasn't associated with 
hCMV-IgG seropositivity. On the other hand there was an 
increasing trend in IgG seropositivity rate with  age, 
increasing parity (p  < 001), increasing gestations and 
decreasing abortion (p= 0.03). Age distribution of hCMV-
IgG positive women are reported in Figure1d. 
Geographical distribution of IgG positive women was 
stable throughout Fars province, with almost no statistical 
difference (p=  0.12). An analysis by two tailed 
independent T test showed hCMV-IgG prevalence rate 
among pregnant and non-pregnant patients was almost 
similar (p= 0.1). Also there was no correlation (p= 0.1) 
between marital statue and the rate of IgG 
seroprevalence. 
Surprisingly statistical analysis during five years 
revealed that unlike IgM, IgG seroprevalence had a 
vigorous correlation (p< 0.001) with seasonal fluctuation 
especially in mothers: An increase in IgG positivity during 
fall/winter, versus a decrease during spring/summer 
(Figure 1a, 1b). 
84% (708/844) of cases were resistant, while 5.5% 
(47/844) were susceptible to hCMV primary infections. A 
comparative correlation of two hCMV-IgG serogroups 
with hematological indexes and epidemiological risk 
factors is reported in Table 2. 
 
DISCUSSION 
 
The prevalence of hCMV antibodies during childbearing 
age is variable in the world. IgG prevalence is between 
40% to 100%; while IgM seroprevalence rate is between 
0% to 10%, depending on the variability of viral 
accessibility and its circulation rate in the community 
(Ray and Mahajan,1997; Mustakangas et al., 2000; 
Turbadkar et al., 2000; Brooks et al., 2001; Munro et al., 
2005). As previously mentioned, our study indicated that 
IgG seroprevalence rate was 93.0 % that is comparable 
with those of developing countries (90% - 100%) (Brooks 
et al., 2001; Munro et al., 2005). In contrast, IgM 
seroprevalence rate 5.4% is very close to that reported in 
developed countries (3%-5.5%)  (Ray and Mahajan,1997; 
Mustakangas et al., 2000; Turbadkar et al., 2000; Munro 
et al., 2005).These findings indicated the fact that by the 
age of 44 almost 93% of women had encountered hCMV, 
while active infection due to viral circulation occurred in 
5.4% of the cases during child-bearing age. According to 
previous studies (Stagno et al., 1986) it is estimated that 
up to 1% of fetuses in pregnant women had been 
infected by hCMV via intrauterine infections, of whom 
30% subsequently developed into congenital diseases. Mal. J. Microbiol. Vol 3(2) 2007, pp.23-28 
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As previously described, several epidemiological factors 
including age, parity numbers, number of gestations, 
geographical distribution, socioeconomic provinceus, 
marital provinceus and sexual maturity may contribute to 
hCMV seroprevalence in women of child bearing age 
(Pal et al., 1972; Gambarroto et al., 1977; Mathur et al., 
1981; Venkitaraman et al., 1986; Griffiths et al., 1991; 
Wen et al., 1996; De Jong et al., 1998; Gratacap et al., 
1998; Hizel et al., 1999). 
Age is a determinant factor influencing hCMV 
seroprevalence. Data indicated that there was an 
increasing trend in IgG seropositivity rate with age that is 
in complete concordance with previous findings 
(Gambarroto  et al., 1977; Mathur et al., 1981; 
Venkitaraman et al., 1986; Gratacap et al., 1998). Also 
age group 20-29 was determined as the major age group 
for the occurrence of hCMV primary infections (2.8%). 
Further analysis revealed that most marriages (60%) 
occurred among the recent age group. According to other 
studies this data raises the probable role of sexual 
maturity as a determinative factor of hCMV infections 
(Forbes, 1989; Brooks et al., 2001). 
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Another factor that may contribute in hCMV infection 
prevalence is geographical distribution (Wen et al., 1996; 
Gratacap  et al., 1998; Mustakangas et al., 2000; 
Chakravarty  et al., 2005). Unlike previous studies data 
showed that hCMV-IgG and IgM seroprevalence had no 
significant correlation, with geographical location, even if 
hCMV seroprevalence had higher value in rural as 
compared to those of urban areas. On the other hand 
primary infections rate was higher through out urban 
areas. A hypothesis for the probable role of geographical 
influence upon hCMV seroprevalance might be the route 
of infection. In rural areas saliva is probably the main 
route through which the virus is transmitted postnatally. 
This is likely to be the route through which the virus is 
transmitted early in life amongst infants and young 
children due to poor sanitation (Forbes, 1989). On the 
other hand in urban areas sexual transmission seems to 
be the major route of infection later in life during child–
bearing age.  
Other factors that may contribute to the hCMV 
seroprevalence are parity and gestation numbers. In our 
study perity and gestations numbers were correlated with 
hCMV seroprevalance.Further analysis with Pearson 
partial correlation test showed these correlations weren't 
due to the influence of age interference: the impact of 
age did not increase enhancing impact of parity ang 
gestation . These findings are in complete concordance 
with previous findings (Gaytant et al., 2002; Boppana et 
al., 1992;  Fowler  et al., 1992; Gratacap et al., 1998; 
Turbadkar et al., 2000). 
In contrast with previous studies that ruled out the 
influence of seasonal fluctuation on hCMV 
seroprevalence (Brooks et al., 2001), hCMV-IgG 
seroprevalence was higher during fall/winter versus 
spring/summer. Further analysis revealed the difference 
is due probably to combinatorial role of day caring 
centers in transmitting hCMV infection from children to 
mothers (Forbes, 1989; Gambarroto et al., 1977; 
Gratacap et al., 1998) and periodical working seasons of 
day caring centers during fall/winter seasons versus 
spring /summer: Almost 95% of mothers population was 
resistant to hCMV primary infections due to preexisting 
immunity. Therefore hCMV infections in mother during 
school opening seasons mostly ended up in IgG 
immunity boosting, though reinfection where the hCMV 
strains are different cannot be ruled out (Fowler et al., 
1992). By the way more is needed to be done for further 
confirmation. 
An interesting finding in our study was negative 
association between increasing IgG and obsessive 
abortions. A decrease in abortions might be an indication 
that anti-hCMV maternal immunity could prevent 
abortions due to hCMV infections. Since there wasn't any 
significant correlation between IgG seroprevalence and 
congenital disorders, hCMV-IgG circulating antibody is 
only considered significantly protective against abortion 
versus congenital disorders. In accordance with previous 
studies (Mustakangas et al., 2000) these findings indicate 
that maternal antibodies afford substantial protection to 
the fetus but the protection is imperfect (Fowler et al., 
1992; Boppana et al., 1992). 
Eventually statistical analysis revealed that 
increasing in whole blood cells, lymphocyte and 
Monocyte counts significantly correlated with hCMV 
infections, even if lymphocyte count only correlated with 
primary as compared to recurrent or reinfections .These 
findings suggest that classic hematological patern for 
infectious mononucleosis could be seen only during 
primary infections versus recurrent or reinfections. 
Considering all the epidemiologic factors that may 
contribute to hCMV infection among child-bearing age 
women through out Fars province, we suggest roles of 
age, parity, seasonal fluctuation, geographical position 
and sexual maturity  as the most probable associated 
factors, though these factors are not totally independent 
and should be considered carefully for interrelated 
associations. Since there is no effective therapeutic and 
prophylactics strategies against hCMV infections, primary 
hCMV infections are very challenging health problem 
during pregnancy period. So more emphasis should be 
laid for women of childbearing age, including prospective 
screening program for hCMV infections before 
pregnancy, limited contact with hCMV infected children 
during pregnancy and responsible sexual practices. Also 
for reducing the chance of abortion implications an 
effective hCMV vaccination program should be 
concluded. 
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